DZ Bank’s AstraZeneca AZN Stock Holding History

DZ Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19B	Sell	11,720,479 -1,218,125	-9%	-$229M	1.68%	12
2026 Q1	$2.51B	Buy	+12,938,604	New	+$2.49B	2.23%	6
2024 Q3	–	Sell	-69,755	Closed	-$10.9M	–	991
2024 Q2	$10.9M	Sell	69,755 -1,454	-2%	-$219K	0.01%	332
2024 Q1	$9.65M	Buy	71,209 +23,460	+49%	+$3.11M	0.01%	358
2023 Q4	$6.43M	Buy	47,749 +5,169	+12%	+$672K	0.01%	424
2023 Q3	$5.77M	Sell	42,580 -43,451	-51%	-$5.93M	0.01%	436
2023 Q2	$12.3M	Hold	86,031	–	–	0.02%	307
2023 Q1	$11.9M	Buy	86,031 +17,775	+26%	+$2.39M	0.02%	317
2022 Q4	$9.26M	Sell	68,256 -961	-1%	-$121K	0.02%	357
2022 Q3	$7.59M	Buy	69,217 +8,011	+13%	+$1.02M	0.01%	371
2022 Q2	$8.09M	Buy	61,206 +5,492	+10%	+$721K	0.01%	355
2022 Q1	$7.39M	Sell	55,714 -13,952	-20%	-$1.67M	0.01%	422
2021 Q4	$8.15M	Buy	69,666 +4,014	+6%	+$472K	0.01%	540
2021 Q3	$7.89M	Buy	+65,652	New	+$7.64M	0.01%	419

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DZ Bank's AZN Position: Q2 2026 in Review

DZ Bank reduced its AstraZeneca (AZN) stake by 9.4% in Q2 2026, selling an estimated $229M and leaving 11,720,479 shares worth $2.19B. The position accounts for 1.68% of the portfolio, ranked #12.

DZ Bank first reported a position in AZN in Q3 2021 and has held it in 14 quarters since. The position peaked at $2.51B in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

DZ Bank held 11,720,479 shares of AstraZeneca worth $2.19B as of Q2 2026.
DZ Bank sold 1,218,125 AstraZeneca shares in Q2 2026, an estimated $229M.
AstraZeneca made up 1.68% of DZ Bank's portfolio in Q2 2026, its #12 holding.
DZ Bank first reported a position in AstraZeneca in Q3 2021 and has held it in 14 quarters since.
DZ Bank's AstraZeneca position peaked at $2.51B in Q1 2026.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.